Inspiration Healthcare Group plc (AIM:IHC)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 25.11M |
| Revenue (ttm) | 45.20M |
| Net Income (ttm) | -11.44M |
| Shares Out | 89.66M |
| EPS (ttm) | -0.13 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 30,486 |
| Average Volume | 103,892 |
| Open | 28.00 |
| Previous Close | 28.00 |
| Day's Range | 28.00 - 28.60 |
| 52-Week Range | 12.30 - 30.00 |
| Beta | 0.72 |
| RSI | 71.63 |
| Earnings Date | Jun 9, 2026 |
About AIM:IHC
Inspiration Healthcare Group plc designs, manufactures, and sells medical technology products worldwide. The company offers products for acute care comprising developmental and intensive care, monitoring, neonatal, obstetrics, operating theatres, pain management and developmental, respiratory, resus, thermo regulatory, and transport areas. It also offers infusion therapies and products, such as ambulatory infusion pumps, administration sets, accessories, patient infusion management systems, and medical infusion devices for acute pain management... [Read more]
Financial Performance
In fiscal year 2025, AIM:IHC's revenue was 38.25 million, an increase of 1.65% compared to the previous year's 37.63 million. Losses were -14.97 million, 148.0% more than in 2024.
Financial StatementsNews
AIM Market Roundup: Premier African, Empyrean, Inspiration Healthcare
Premier African, Empyrean, Inspiration Healthcare are today's top risers, while IQE, WH Ireland take the biggest fall on London's AIM market
AIM Market Roundup: Sancus Lending, Ovoca Bio, Inspiration Healthcare
Sancus Lending, Ovoca Bio, Inspiration Healthcare are today's top risers, while MobilityOne, Public Policy take the biggest fall on AIM
Inspiration Healthcare Group Earnings Call Transcript: H1 2026
Record H1 revenue and return to profitability driven by major export contracts and underlying growth. Gross margin and cash flow improved, with reduced net debt and strong outlook for H2. Strategic focus on U.S. market entry, operational efficiency, and brand realignment.
Inspiration Healthcare posts record half-year revenues as turnaround gathers pace
Inspiration reported record half-year revenues of £24m for the six months to 31 July 2025, a 41% increase on the previous year.
Inspiration Healthcare Group Earnings Call Transcript: H2 2025
FY25 saw organizational restructuring, cost savings, and a strong H2 turnaround, with infusion therapy and Aeron segments outperforming. Gross margin declined, but large new contracts and a focus on recurring revenue and operational efficiency support a positive FY26 outlook.
AIM Market Roundup: Arkle Resources, Galantas, Tracsis
Arkle Resources, Galantas, Tracsis, TheraCryf, Inspiration Healthcare are today's biggest risers and fallers on London's AIM market
AIM Market Roundup: Inspiration Healthcare up 84%
Inspiration Healthcare, Seeen, Blue Star Capital, Deltic Energy, Europa Metals are today's biggest risers and fallers on London's AIM market